ANI PHARMACEUTICALS, INC Investment Income, Net
ANI PHARMACEUTICALS, INC (ANIP) reported Investment Income, Net of $1.52 thousand for the 3-month period ending 2011-09-30, per its 10-Q filed 2011-11-09.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeNet · last filed 2011-11-09
- ANI PHARMACEUTICALS, INC investment income, net for the quarter ending 2011-09-30 was $1.52K, a 72.26% decline year-over-year.
- ANI PHARMACEUTICALS, INC investment income, net for the quarter ending 2011-06-30 was $1.71K.
- ANI PHARMACEUTICALS, INC investment income, net for the quarter ending 2010-09-30 was $5.47K.
| Period end | Investment Income, Net 3 month | Investment Income, Net 6 month | Investment Income, Net 9 month |
|---|---|---|---|
| 2011-09-30 | $1.52K 10-Q · filed 2011-11-09 | $3.23K derived: sum of 2 quarters · filed 2011-11-09 | $6.47K 10-Q · filed 2011-11-09 |
| 2011-06-30 | $1.71K 10-Q · filed 2011-08-05 | $4.96K 10-Q · filed 2011-08-05 | |
| 2010-09-30 | $5.47K 10-Q · filed 2011-11-09 | $5.47K 10-Q · filed 2011-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |